Found: 39
Select item for more details and to access through your institution.
Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 5, p. 304, doi. 10.1002/acr2.11657
- By:
- Publication type:
- Article
Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12969-020-0413-7
- By:
- Publication type:
- Article
Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
- Published in:
- Pediatric Rheumatology, 2017, v. 15, p. 1, doi. 10.1186/s12969-017-0196-7
- By:
- Publication type:
- Article
Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 8, p. 2319, doi. 10.1007/s10067-022-06116-z
- By:
- Publication type:
- Article
Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 10, p. 1409, doi. 10.1002/acr.25377
- By:
- Publication type:
- Article
Effectiveness and Safety of High‐Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 11, p. 1770, doi. 10.1002/acr.24727
- By:
- Publication type:
- Article
Parent‐Reported Medication Side Effects and Their Impact on Health‐Related Quality of Life in Children With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 10, p. 1567, doi. 10.1002/acr.24610
- By:
- Publication type:
- Article
Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Worse Quality of Life, Function, and Pain in Children With Enthesitis, Irrespective of Their Juvenile Arthritis Category.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trends in Population-Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Characteristics and Course of Enthesitis in a Juvenile Idiopathic Arthritis Inception Cohort.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Health-Related Quality of Life in an Inception Cohort of Children With Juvenile Idiopathic Arthritis: A Longitudinal Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Unpacking Early Work Experiences of Young Adults With Rheumatic Disease: An Examination of Absenteeism, Job Disruptions, and Productivity Loss.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases.
- Published in:
- Arthritis Care & Research, 2013, v. 65, n. 1, p. 113, doi. 10.1002/acr.21785
- By:
- Publication type:
- Article
Evaluating Quality of Care for Rheumatoid Arthritis for the Population of Alberta Using System-level Performance Measures.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Validation of administrative health data for the pediatric population: a scoping review.
- Published in:
- BMC Health Services Research, 2014, v. 14, n. 1, p. 368, doi. 10.1186/1472-6963-14-236
- By:
- Publication type:
- Article
Validation of administrative health data for the pediatric population: a scoping review.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
- Published in:
- BMC Rheumatology, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41927-023-00329-8
- By:
- Publication type:
- Article
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 487, doi. 10.1007/s40801-024-00428-z
- By:
- Publication type:
- Article
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 617, doi. 10.1007/s40801-022-00326-2
- By:
- Publication type:
- Article
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 804, doi. 10.1093/rheumatology/keac335
- By:
- Publication type:
- Article
Causal pathways to health-related quality of life in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4691, doi. 10.1093/rheumatology/keab079
- By:
- Publication type:
- Article
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 6, p. 699, doi. 10.1007/s40272-022-00533-y
- By:
- Publication type:
- Article
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00885-w
- By:
- Publication type:
- Article
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 2, p. 425, doi. 10.1007/s40744-024-00642-9
- By:
- Publication type:
- Article
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1479, doi. 10.1007/s40744-023-00582-w
- By:
- Publication type:
- Article
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 4, p. 983, doi. 10.1007/s40744-023-00556-y
- By:
- Publication type:
- Article
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 659, doi. 10.1007/s40744-023-00533-5
- By:
- Publication type:
- Article
The Effect of Guselkumab on Work Productivity in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Effect of Guselkumab on General Health State in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article